Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monocular Markerless Motion Capture Enables Quantitative Assessment of Upper Extremity Reachable Workspace.

Sensors (Basel, Switzerland)ยท2026
Same author

Polygenic Stroke Risk and Autoimmune Disease: Associations and Clinical Modifiers.

IEEE transactions on bio-medical engineeringยท2026
Same author

Governing real-world health data as a public utility.

Science (New York, N.Y.)ยท2026
Same author

Multi-level Asymmetric Contrastive Learning for Medical Image Segmentation Pre-training.

IEEE journal of biomedical and health informaticsยท2026
Same author

BMRetriever: Tuning Large Language Models as Better Biomedical Text Retrievers.

Proceedings of the Conference on Empirical Methods in Natural Language Processing. Conference on Empirical Methods in Natural Language Processingยท2026
Same author

Knowledge-Infused Prompting: Assessing and Advancing Clinical Text Data Generation with Large Language Models.

Findings of ACL. ACLยท2026
Same journal

Analysis of End-Tidal CO2 Variability During Plateau Waves Episodes: An Information Theoretic Approach<sup></sup>.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conferenceยท2025
Same journal

AI and Tomosynthesis for Breast Cancer Molecular Subtyping: A step toward precision medicine<sup></sup>.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conferenceยท2025
Same journal

Towards Sustainable Protein Recovery from Biological Waste: Assessing Polyethersulfone-based Microfiltration.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conferenceยท2025
Same journal

Analysis of the cardiovascular response to standardized polymicrobial peritonitis experimental model.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conferenceยท2025
Same journal

Automated Wrist Ultrasound Image Bone Enhancement and Segmentation Using Deep Learning.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conferenceยท2025
Same journal

A Deep Learning approach for Depressive Symptoms assessment in Parkinson's disease patients using facial videos.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conferenceยท2025
See all related articles

Related Experiment Video

Updated: Jun 6, 2026

A Web Tool for Generating High Quality Machine-readable Biological Pathways
08:01

A Web Tool for Generating High Quality Machine-readable Biological Pathways

Published on: February 8, 2017

WebPK, a web-based tool for custom pharmacokinetic simulation.

Jaydeep Srimani1, Richard A Moffitt, May D Wang

  • 1department of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA. jaydeep.srimani@gatech.edu

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
|November 25, 2010
PubMed
Summary
This summary is machine-generated.

WebPK is a new web-based tool that simulates custom pharmacokinetic models, addressing drug bioavailability issues. This allows for personalized drug dosing and improved therapeutic outcomes for patients.

More Related Videos

An Open-Source Framework for Mass Calculation of Antibody-Based Therapeutic Molecules
04:24

An Open-Source Framework for Mass Calculation of Antibody-Based Therapeutic Molecules

Published on: June 16, 2023

Related Experiment Videos

Last Updated: Jun 6, 2026

A Web Tool for Generating High Quality Machine-readable Biological Pathways
08:01

A Web Tool for Generating High Quality Machine-readable Biological Pathways

Published on: February 8, 2017

An Open-Source Framework for Mass Calculation of Antibody-Based Therapeutic Molecules
04:24

An Open-Source Framework for Mass Calculation of Antibody-Based Therapeutic Molecules

Published on: June 16, 2023

Area of Science:

  • Pharmacokinetics and drug development
  • Computational biology
  • Personalized medicine

Background:

  • Drug bioavailability is a critical challenge in pharmaceutical development, leading to therapeutic failure.
  • Patient-specific variability in drug metabolism and distribution complicates effective dosing.
  • Existing pharmacokinetic modeling tools may lack accessibility or user-friendliness.

Purpose of the Study:

  • To introduce WebPK, a novel web-based platform for simulating custom pharmacokinetic models.
  • To provide a user-friendly tool for analyzing drug biodistribution and patient-specific drug behavior.
  • To facilitate personalized drug regimen design for improved patient outcomes.

Main Methods:

  • Development of a server-side simulation engine for pharmacokinetic models.
  • Implementation of manual parameter entry and file upload functionalities.
  • Generation of time-series biodistribution data in graphical and numerical formats.

Main Results:

  • WebPK successfully simulates custom pharmacokinetic models with server-side computation.
  • The tool provides accessible, mobile-compatible pharmacokinetic profile simulations.
  • Generated results are consistent with established pharmacokinetic models, validating the platform's accuracy.

Conclusions:

  • WebPK offers an accessible solution for simulating patient-specific pharmacokinetic profiles.
  • The tool empowers physicians to design more efficient and personalized drug regimens.
  • This advancement is expected to enhance drug efficacy and reduce therapeutic variability.